List
The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until April, 2020.
-
Hierarchical, Layout-Aware, Radiation Effects Tools Vertically Integrated into an EDA Design Flow for Rad-Hard by Design
SBC: Reliable MicroSystems, LLC Topic: DTRA16A003The goal of this workis to establish a radiation-aware capability in a commercial EDA design flow that will enable first-pass success in radiation resiliency for DoD ASIC designs in much the same way that existing EDA design suites ensure first pass functionality and performance success of complex ASICs destined for commercial applications.Such an integrated capability does not presently exist.The ...
STTR Phase II 2018 Department of DefenseDefense Threat Reduction Agency -
Enabling point of care molecular diagnostics by developing an adaptive PCR instrument and on demand kit reagents
SBC: BIOVENTURES, INC Topic: 172Because of its high sensitivity polymerase chain reaction PCR is the gold standard for the diagnosis of many infectious diseases but generally only implemented in well equipped laboratories One of the major roadblocks for expanding PCR to point of care markets is the lack of simple robust single tube PCR designs which preserve its laboratory based high sensitivity and specificity In this F ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Turnkey THz Spectroscopy Polarimetry System for Pharmaceutical Applications
SBC: Microtech Instruments, Inc. Topic: 400ABSTRACT SUMMARY The outcome of this phase project will yield a turnkey system for spectroscopy polarimetry in the terahertz THz frequency range designed to support development of new drugs This system will directly probe protein vibrations using polarized terahertz radiation allowing researchers to rapidly characterize intramolecular vibrations which will help identify sites on ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
DRα MOG A Novel Immunomodulatory Therapeutic for Stroke
SBC: Virogenomics BioDevelopment Inc Topic: 105This is a Phase I STTR to investigate the preclinical efficacy of a novel immunomodulator DR MOG in a clinically relevant thromboembolic stroke model in mice We have previously shown that T cells are activated after stroke infiltrate brain and exacerbate ischemic brain damage Strategies that reduce T cell activation and brain tissue infiltration have been investigated as potential therapeu ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Identifying activators of interferon regulatory factors for neuroprotection
SBC: Neuralexo, LLC Topic: 106Abstract Stroke is a leading cause of morbidity and mortality in the United States However less than of patients are eligible for the current approved interventions of tissue plasminogen activator or thrombectomy We seek to develop new therapeutics to reduce the extent of damage and functional impairment resulting from ischemic injury to the brain an area of significant unmet medical need ...
STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Innovative Mitigation of Radiation Effects in Advanced Technology Nodes
SBC: Reliable MicroSystems, LLC Topic: DTRA16A003Establish a radiation-aware analysis capability in a commercial EDA design flow that will enable first-pass success in radiation-hardened by design (RHBD) for DoD ASICs in much the same way that existing EDA design suites ensure first pass functionality and performance success of complex ASICs destined for commercial applications. Layout-aware, calibrated single-event radiation models that captur ...
STTR Phase I 2016 Department of DefenseDefense Threat Reduction Agency -
Expressing humanized bacterial luciferase in stem cells: Moving beyond firefly luciferase to expand the informational capacity of animal models for regenerative medicine
SBC: 490 BIOTECH INC Topic: 200DESCRIPTION provided by applicant This Small Business Technology Transfer STTR Phase I project proposes to develop autonomously bioluminescent human stem cells for continuous reagent free and real time bioimaging to address the National Institutes of Healthandapos s request for new techniques for non invasive long term tracking of stem cell survivability engraftment and migration followi ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Development of novel compounds for the treatment of atrial fibrillation
SBC: Elex Biotech, Inc Topic: NHLBIDESCRIPTION provided by applicant Atrial fibrillation AF is the most prevalent type of cardiac arrhythmia in the developed world affecting million people in the United States alone a number that is expected to double by because of population aging Current pharmacological options are ineffective which may be in part because these drugs fail to target key pathogenic mechanisms Recen ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
StrikeVEMP: Automated Portable Bone-Conducted Force Stimuli for Recording Acceleration-Produced coVEMPs
SBC: Ear And Skull Base Center, Inc. Topic: NIDCDDESCRIPTION provided by applicant Each year million Americans go to health care providers because of vertigo dizziness or balance problems It is the second most common complaint heard in doctorandapos s offices and will occur in of the nationandapos s population at sometime in their lives From through of US adults aged years and older million Americans had ve ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Preclinical and neuroimmunologic study of RTL1000 for methamphetamine addiction
SBC: Virogenomics BioDevelopment Inc Topic: R41DESCRIPTION provided by applicant Methamphetamine MA dependence is associated with long term damage to regions of the brain that control cognitive and psychiatric function One third to one half of MA dependent adults experience persistent cognitive and other psychiatric disorders up to three years or longer into remission The neuropsychiatric impairments that persist following abstinence ar ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health